89694-54-2

Usage

Uses

Used in Pharmaceutical Research:
2-Bromo-3-ethoxypyridine is used as a valuable building block for the development of new pharmaceuticals. Its reactivity and ability to participate in various chemical reactions make it suitable for the synthesis of diverse organic compounds with potential therapeutic applications.
Used in Agrochemical Development:
2-Bromo-3-ethoxypyridine is used as an intermediate in the synthesis of agrochemicals. Its versatile chemical properties allow for the creation of new molecules with potential applications in agriculture, such as pesticides or herbicides.
Used in Organic Synthesis:
2-Bromo-3-ethoxypyridine is used as a key intermediate in organic synthesis. Its reactivity and compatibility with various reaction conditions make it a preferred choice for researchers and chemists working on the development of new organic compounds for various applications.
Used in Research and Development Laboratories:
2-Bromo-3-ethoxypyridine is widely used in research and development laboratories for the synthesis of diverse organic compounds. Its unique properties and reactivity make it an essential tool for scientists working on the discovery and development of new molecules with potential applications in various industries.

InChI:InChI=1/C7H8BrNO/c1-2-10-6-4-3-5-9-7(6)8/h3-5H,2H2,1H3

Upstream product

• 14773-50-3 3-ethoxypyridine 
• 626-55-1 3-Bromopyridine 
• 74037-50-6 3-ethoxy-2-nitropyridine 
• 10035-10-6 hydrogen bromide 
• 64-19-7 acetic acid 
• 6602-32-0 2-bromo-pyridin-3-ol 
• 75-03-6 ethyl iodide 

Downstream Products

• 170856-57-2 N-(1-benzylpiperidin-4-yl)-N-(3-ethoxypyridin-2-yl)-methylamine 
• 89943-11-3 2-amino-5-ethoxypyridine 
• 179556-80-0 (5-Amino-1H-indol-2-yl)-{4-[(3-ethoxy-pyridin-2-yl)-methyl-amino]-piperidin-1-yl}-methanone 
• 170856-58-3 N-(piperidin-4-yl)-N-(3-ethoxypyridin-2-yl)methylamine 
• 16867-04-2 dihydroxypyridine 
• 6636-78-8 2-chloro-3-hydroxypyridine 
• 137347-01-4 3-ethoxy-2-bromo-6-nitro-pyridine 
• 63756-60-5 2,3-diethoxy-pyridine 

Relevant academic research and scientific papers

Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections

Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).

PYRAZOLES USEFUL IN THE TREATMENT OF INFLAMMATION

There is provided compounds of formula (I), wherein R1, R2, X1, X2 and n have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.

TRIAZOLE COMPOUNDS AS LIPOXYGENASE INHIBITORS

There is provided compounds of formula (I) wherein W is an optionally substituted aryl or heteroaryl group, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15- lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.

Positive allosteric modulators of the nicotinic acetylcholine receptor

The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.

Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds

Anti-AIDS compounds of formula (I) STR1 wherein R1, R2, R3, R4, R5, R6, and R7 are as defined in the specification and R8 is alkyl of substituted alkyl.

Heterocyclic compounds for the treatment of CNS and cardiovascular disorders

Novel aromatic bicyclic amines of formula (I) STR1 are useful in treating central nervous system disorders and cardiac arrhythmias and cardiac fibrillation.

Synthesis and bioactivity of novel bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: Structure-activity relationships and increased metabolic stability of novel substituted pyridine analogs

The major route of metabolism of the bis(heteroaryl)piperazine (BHAP) class of reverse transcriptase inhibitors (RTIs), atevirdine and delavirdine, is via oxidative N-dealkylation of the 3-ethyl- or 3-isopropylamino substituent on the pyridine ring. This